Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetes - Weir, Matthew R.; Chen, Yen-Wen; He, Jinghua; Bookhart, Brahim; Campbell, Alicia; Ashton, Veronica (Journal of diabetes and its complications, 2021)
Keywords: Algorithms; Anticoagulants; Anticoagulants - adverse effects; Anticoagulants - therapeutic use; Anticoagulation; Antidiabetics; Atrial Fibrillation - complications; Atrial Fibrillation - drug therapy; Atrial Fibrillation - epidemiology; Body mass index; Cardiac arrhythmia; Comorbidity; Diabetes; Diabetes mellitus; Diabetes Mellitus - drug therapy; Diabetes Mellitus - epidemiology; Embolism; Gastrointestinal surgery; Generic products; Health care policy; Hemorrhage - chemically induced; Hemorrhage - epidemiology; Humans; Medicare; Nonvalvular atrial fibrillation; Obesity; Obesity - complications; Obesity - epidemiology; Pharmacy; Population; Retrospective Studies; Rivaroxaban; Rivaroxaban - adverse effects; Rivaroxaban - therapeutic use; Stroke; Stroke - epidemiology; Stroke - etiology; Stroke - prevention & control; Treatment Outcome; Warfarin; Warfarin - adverse effects; Warfarin - therapeutic use; United States--US; Obesity; Rivaroxaban; Warfarin; Anticoagulation; Nonvalvular atrial fibrillation; Diabetes mellitus